Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 20, Issue 3 , Pages 421-432 , June 2006

Access to safe abortion within the limits of the law

  • Kamini A. Rao, MBBS, DGO, DORCP(UK), MCh(UK), FRCOG, PGDMLE(Law), FNAMS (Medical Director)
  • Anibal Faúndes, MD (Professor of Obstetrics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +55 19 3289 2856; Fax: +55 19 3289 2440.

References 

  1. World Health Organization . Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths: modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977;56:247–253
  2. Schenker JG, Cain JM. International Federation of Gynecology and Obstetrics Committee for the ethical aspects of human reproduction and women's health. Int J Gynaecol Obstet. 1999;64:317–322
  3. AbouZahr C, Ahman E. Unsafe abortion and ectopic pregnancy. In:  Murray CJL,  Lopez AD editor. Health Dimensions of Sex and Reproduction: the Global Burden of Sexually Transmitted Diseases, HIV, Maternal Conditions, Perinatal Disorders, and Congenital Anomalies. Cambridge, MA: Harvard University; 1998;p. 266–296
  4. Report of the International Conference on Population and Development, Cairo, 5–13 September 1994. United Nations publication, Sales No. E.95.XIII.18. Chap. I, Resolution 1, Annex. NY: United Nations; 1995.
  5. World Health Organization . Safe Abortion: Technical and Policy Guidance for Health Systems. 1st edn. Geneva: WHO; 2003;pp. 106
  6. Department for Economic and Social Information and Policy Analysis . World Population Prospects: the 2000 Revision. New York: United Nations; 2001;
  7. Henshaw SK, Singh S, Haas T. The incidence of abortion worldwide. Int Fam Plann Perspect. 1999;25(supplement):30–38
  8. Faúndes A, Barzelatto J. The Human Drama of Abortion: a Global Search for Consensus. 1st edn. Norman, Oklahoma: Vanderbilt University Press; 2006;
  9. World Health Organization . Unsafe Abortion: Global and Regional Estimates of Incidence of Unsafe Abortion and Associated Mortality in 2000. 4th edn. 2004;http://www.who.int/reproductive-health/publications/unsafe_abortion_estimates_04/estimates.pdfLast accessed 20 January 2006
  10. The Alan Guttmacher Institute . Sharing Responsibility. Women, Society and Abortion Worldwide. p. 37 1999;http://www.agi-usa.org/pubs/sharing.pdfLast accessed 20 January 2006
  11. Richards A, Lachman E, Pitsoe SB, Moodley J. The incidence of major abdominal surgery after septic abortion – an indicator of complications due to illegal abortion. S Afr Med J. 1985;68:799–800
  12. Briozzo L, Rodriguez F, Leon I, Vidiella G, Ferreiro G, Pons JE. Unsafe abortion in Uruguay. Int J Gynaecol Obstet. 2004;85:70–73
  13. World Health Organization . Unsafe Abortion: Global and Regional Estimates of Incidence of and Mortality Due to Unsafe Abortion with a Listing of Available Country Data. 3rd edn. Geneva: World Health Organization, Division of Reproductive Health (Technical Support); 1997;
  14. Faúndes A, Santos LC, Carvalho M, Gras C. Post abortion complications after interruption of preganancy with misoprostol. Adv Contracept. 1996;12:1–9
  15. Viggiano M, Faúndes A, Borges AL, Viggiano ABF, Souza GR, Rebello I. Disponibilidade de misoprostol e complicações de aborto provocado em Goiânia. Jornal brasileiro de Ginecologia. 1996;106:55–61
  16. Zhirova IA, Frolova OG, Astakhova TM, Ketting E. Abortion-related maternal mortality in the Russian Federation. Stud Fam Plann. 2004;35:178–188
  17. Grimes DA, Schulz KF. Morbidity and mortality from second-trimester abortions. J Reprod Med. 1985;30:505–514
  18. Nagaya K, Fetters MD, Ishikawa M, et al. Causes of maternal mortality in Japan. JAMA. 2000;283:2661–2667
  19. Tietze C, Henshaw SK. Induced Abortion: A World Review. 6th edn. New York: The Alan Guttmacher Institute; 1986;Table 1, pp. 12–14
  20. Stephenson P, Wagner M, Badea M, Serbanescu F. Commentary: The public health consequences of restricted induced abortion. Lessons from Romania. Am J Public Health. 1992;82:1328–1331
  21. United Nations. Report of the Fourth World Conference on Women. Beijing, 4–15 September 1995. NY: United Nations; 1995.
  22. Committee on the Elimination of Discrimination against Women. General recommendation 24: Women and Health (20th Sess., 1999), in Compilation of General Comments and General Recommendations by Human Rights Treaty Bodies, at 244, §11, U.N. Doc. HRI/GEN/1/Rev.5 (2001).
  23. Cook R, Dickens BM, Fathalla MF. Reproductive Health and Human Rights. New York: Oxford University Press; 2003;pp. 351–353
  24. von Hertzen H, Honkanen J, Piaggio G, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Br J Obstet Gynaecol. 2003;110:808–818
  25. Honkanen H, Piaggio G, Hertzen H, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. Br J Obstet Gynaecol. 2004;111:715–725
  26. Kulier R, Gulmezoglu AM, Hofmeyr GJ, Cheng LN, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004;CD002855
  27. Nothnagle M, Taylor JS. Medical methods for first-trimester abortion. Am Fam Physician. 2004;70:81–83
  28. Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol. 2004;104:174–185
  29. Cates W, Grimes DA, Smith JC, Tyler CW. Legal abortion mortality in the United States: epidemiologic surveillance, 1972–1974. JAMA. 1997;237:452–455
  30. Hart G, Macharper T. Clinical aspects of induced abortion in South Australia from 1970 to 1984. Aust NZ J Obstet Gynaecol. 1986;26:219–224
  31. Greenslade FC, Benson J, Winkler J, Henderson V, Wolf M, Leonard A. Summary of clinical and programmatic experience with manual vacuum aspiration. IPAS (Carrboro, NC). 1993;3:1–4
  32. Autry AM, Hayes EC, Jacobson GF, Kirby RS. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol. 2002;187:393–397
  33. Stubblefield PG, Carr-Ellis S, Borgatta L. Methods for induced abortion. Obstet Gynecol. 2005;105:221–222
  34. Tang OS, Mok KH, Ho PC. A randomized study comparing the use of sublingual to vaginal misoprostol for pre-operative cervical priming prior to surgical termination of pregnancy in the first trimester. Hum Reprod. 2004;19:1101–1104
  35. Goldberg AB, Drey EA, Whitaker AK, et al. Misoprostol compared with laminaria before early second-trimester surgical abortion: a randomized trial. Obstet Gynecol. 2005;106:234–241
  36. Bugalho A, Bique C, Almeida L, Faúndes A. The effectiveness of intravaginal misoprostol (Cytotec) in inducing abortion after eleven weeks of pregnancy. Stud Fam Plann. 1993;24:319–323
  37. Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Pract Res Clin Obstet Gynaecol. 2003;17:765–775
  38. Tang OS, Ho PC. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol. 2002;16:237–246
  39. Tang OS, Lau WN, Chan CC, Ho PC. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. Br J Obstet Gynaecol. 2004;111:1001–1005
  40. Tang OS, Chan CC, Kan AS, Ho PC. A prospective randomized comparison of sublingual and oral misoprostol when combined with mifepristone for medical abortion at 12–20 weeks gestation. Hum Reprod. 2005;20:3062–3066
  41. Hamoda H, Ashok PW, Flett GM, Templeton A. Hum Reprod. 2005;20:2348–2354
  42. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. Br J Obstet Gynaecol. 2004;111:148–153
  43. Velazco A. Aborto Terapéutico. In: Faundes A  editors. Uso de misoprostol em Obstetrícia y Ginecologia. Santa Cruz, Bolívia: Federación Latinoamericana de Sociedades de Ginecologia y Obstetrícia; 2005;p. 61–78
  44. le Roux PA, Pahal GS, Hoffman L, et al. Second trimester termination of pregnancy for fetal anomaly or death: comparing mifepristone/misoprostol to gemeprost. Eur J Obstet Gynecol Reprod Biol. 2001;95:52–54
  45. Berghahn L, Christensen D, Droste S. Uterine rupture during second-trimester abortion associated with misoprostol. Obstet Gynecol. 2001;98:976–977
  46. Daskalakis GJ, Mesogitis SA, Papantoniou NE, et al. Misoprostol for second trimester pregnancy termination in women with prior cesarean section. Br J Obstet Gynaecol. 2005;112:97–99
  47. Nayki U, Taner CE, Mizrak T. Uterine rupture during second trimester abortion with misoprostol. Fetal Diagn Ther. 2005;20:469–471
  48. Herabutya Y, Chanarachakul B, Punyavachira P. Induction of labor with vaginal misoprostol for second trimester termination of pregnancy in the scarred uterus. Int J Gynaecol Obstet. 2003;83:293–297
  49. Dickinson JE. Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery. Obstet Gynecol. 2005;105:352–356
  50. Faúndes A, Leocadio E, Andalaft J. Making legal abortion accessible in Brazil. Reprod Health Matters. 2002;10:120–127
  51. FLASOG Report . Pre-Congress Workshop on Sexual and Reproductive Rights. Santa Cruz de la Sierra, Bolivia: FLASOG; 2002;
  52. FLASOG Committee on Sexual and Reproductive Rights and Committee for Reducing Maternal and Perinatal Mortality . Report of Pre-Congress Workshop. Santo Domingo, Dominican Republic: FLASOG; 2005;

PII: S1521-6934(06)00034-4

doi: 10.1016/j.bpobgyn.2006.01.020

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 20, Issue 3 , Pages 421-432 , June 2006

Article Tools

* Image Usage & Resolution